ATE197669T1 - Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation - Google Patents

Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation

Info

Publication number
ATE197669T1
ATE197669T1 AT94401461T AT94401461T ATE197669T1 AT E197669 T1 ATE197669 T1 AT E197669T1 AT 94401461 T AT94401461 T AT 94401461T AT 94401461 T AT94401461 T AT 94401461T AT E197669 T1 ATE197669 T1 AT E197669T1
Authority
AT
Austria
Prior art keywords
beta
derivatives
aggregation
naphthochinone
platele
Prior art date
Application number
AT94401461T
Other languages
English (en)
Inventor
Denis Blache
Christian Bloy
Bernard Hercelin
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ATE197669T1 publication Critical patent/ATE197669T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94401461T 1993-07-02 1994-06-28 Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation ATE197669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308112A FR2707495B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (1)

Publication Number Publication Date
ATE197669T1 true ATE197669T1 (de) 2000-12-15

Family

ID=9448828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94401461T ATE197669T1 (de) 1993-07-02 1994-06-28 Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation

Country Status (13)

Country Link
US (1) US5523322A (de)
EP (1) EP0631777B1 (de)
JP (1) JP3993646B2 (de)
AT (1) ATE197669T1 (de)
CA (1) CA2127215C (de)
DE (1) DE69426317T2 (de)
DK (1) DK0631777T3 (de)
ES (1) ES2154286T3 (de)
FR (1) FR2707495B1 (de)
GR (1) GR3035058T3 (de)
HU (1) HU214058B (de)
PT (1) PT631777E (de)
RU (1) RU2122853C1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (fr) * 1997-05-13 1999-05-04 Jose Remacle Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie.
FR2796552A1 (fr) * 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR924M (de) * 1959-09-26 1961-11-13

Also Published As

Publication number Publication date
DK0631777T3 (da) 2001-03-05
DE69426317T2 (de) 2001-05-03
CA2127215A1 (fr) 1995-01-03
DE69426317D1 (de) 2000-12-28
PT631777E (pt) 2001-05-31
EP0631777A1 (de) 1995-01-04
FR2707495A1 (fr) 1995-01-20
RU2122853C1 (ru) 1998-12-10
GR3035058T3 (en) 2001-03-30
EP0631777B1 (de) 2000-11-22
HU214058B (en) 1997-12-29
JP3993646B2 (ja) 2007-10-17
CA2127215C (fr) 2004-10-26
HUT70508A (en) 1995-10-30
HU9401978D0 (en) 1994-09-28
US5523322A (en) 1996-06-04
JPH07145128A (ja) 1995-06-06
ES2154286T3 (es) 2001-04-01
RU94022757A (ru) 1996-09-27
FR2707495B1 (fr) 1995-09-01

Similar Documents

Publication Publication Date Title
DK0530505T3 (da) Hydantoinderivater
ATE175669T1 (de) Sulfonylaminopyrimidine, ihre herstellung und verwendung als heilmittel
ATE415394T1 (de) Zwischeprodukte zur herstellung von retroviralen protease-hemmern
AU1611192A (en) Fibrinogen receptor antagonists
EP0350846A3 (en) Condensed heterocyclic compounds and their use in therapy
FI940072A0 (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
UA39849C2 (uk) ПОХІДНІ N-АЦИЛ-&lt;font face=&#34;Symbol&#34;&gt;a&lt;/font&gt;-АМІНОКИСЛОТИ АБО ЇХ ФІЗІОЛОГІЧНО ПРИЙНЯТНІ СОЛІ, ПРОСТІ АБО СКЛАДНІ ЕФІРИ, АМІДИ АБО ЇХ ГІДРАТИ ЯК ФАРМАЦЕВТИЧНО АКТИВНІ РЕЧОВИНИ
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
EP0614913A3 (de) Dynorphin Derivate.
DE59407431D1 (de) Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE58906387D1 (de) Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica.
DE3861380D1 (de) Fluessigkristallverbindung vom tolan-typ.
ATE132861T1 (de) Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATE57095T1 (de) Verwendung von hydroxyindolderivaten zur herstellung eines arzneimittels zur senkung des blutdrucks.
ATE197669T1 (de) Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation
DE69426316T2 (de) Verwendung von Beta-Naphthochinonderivaten zur Beschleunigung der Proliferation der Endothelzellen und Inhibierung der NO-Synthasen
ATE142225T1 (de) Neues hexapeptid
ES8605247A1 (es) Procedimiento para la obtencion de arisulfonilguanidinas sustituidas
YU47723B (sh) Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina
DE3762854D1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
FR2627487B1 (fr) Nouveau derive de l&#39;acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner